Evidence map›Paper›PMID 35005197›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2021

Deep learning improves utility of tau PET in the study of Alzheimer's disease.

James Zou, David Park, Aubrey Johnson, Xinyang Feng, Michelle Pardo, Jeanelle France, Zeljko Tomljanovic, Adam M Brickman, Devangere P Devanand, José A Luchsinger and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. LNODE: Uncovering the Latent Dynamics ofMedical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Deep learning improves utility of tau PET in the study of Alzheimer's disease.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

James ZouThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
David ParkThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Aubrey JohnsonThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Xinyang FengThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Michelle PardoDepartment of Medicine Columbia University Medical Center New York New York USA.
Jeanelle FranceThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Zeljko TomljanovicThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Adam M BrickmanThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Devangere P DevanandThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
José A LuchsingerDepartment of Medicine Columbia University Medical Center New York New York USA.
William C KreislThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Frank A ProvenzanoThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.
Alzheimer's Disease Neuroimaging Initiative
MIND Research Institute · USColumbia University Irving Medical Center · USColumbia University · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Diabetes Status and Brain Amyloid in Middle Aged HispanicsR01AG050440 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LUCHSINGER, JOSE ALEJANDRO · 2015 to 2025
$21.9M
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEP01AG007232 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SCHUPF, NICOLE · 1989 to 2008
$21.7M
Anti-Viral therapy in Alzheimer's diseaseR01AG055422 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEVANAND, DAVANGERE P · 2017 to 2021
$10.6M
Epidemiology of Biomarkers of Risk and Progression in LOADR01AG037212 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, SCHUPF, NICOLE · 2010 to 2015
$10.1M
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers diseaseRF1AG051556 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRICKMAN, ADAM M, LUCHSINGER, JOSE ALEJANDRO · 2015 to 2019
$9.7M
Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's DiseaseRF1AG054023 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P · 2016 to 2018
$8.9M
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?R01AG055299 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LUCHSINGER, JOSE ALEJANDRO · 2017 to 2022
$7.4M
The Brief Research in Aging and Interdisciplinary NeurosciencesT35AG044303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sachin Agarwal, Jennifer Jaie Manly · 2013 to 2026
$1.9M
Midcareer Award for Research in Dementia Risk Factors and PreventionK24AG045334 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jose Alejandro Luchsinger · 2016 to 2026
$1.5M
Understanding the mechanisms linking small vessel cerebrovascular disease and Alzheimer's disease pathophysiology with neurodegeneration and cognition during midlifeK99AG065506 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LAO, PATRICK JORDAN · 2020 to 2021
$260k
NCATS NIH HHS UL1 TR001873NIA NIH HHS K24 AG045334NIA NIH HHS K99 AG065506NIA NIH HHS P01 AG007232NIA NIH HHS R01 AG037212NIA NIH HHS R01 AG050440NIA NIH HHS R01 AG055299NIA NIH HHS R01 AG055422NIA NIH HHS RF1 AG051556NIA NIH HHS RF1 AG054023NIA NIH HHS T35 AG044303NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

introductionPositron emission tomography (PET) imaging targeting neurofibrillary tau tangles is increasingly used in the study of Alzheimer's disease (AD), but its utility may be limited by conventional quantitative or qualitative evaluation techniques in earlier disease states. Convolutional neural networks (CNNs) are effective in learning spatial patterns for image classification.

methods18F-MK6240 (n = 320) and AV-1451 (n = 446) PET images were pooled from multiple studies. We performed iterations with differing permutations of radioligands, heuristics, and architectures. Performance was compared to a standard region of interest (ROI)-based approach on prediction of memory impairment. We visualized attention of the network to illustrate decision making.

resultsOverall, models had high accuracy (> 80%) with good average sensitivity and specificity (75% and 82%, respectively), and had comparable or higher accuracy to the ROI standard. Visualizations of model attention highlight known characteristics of tau radioligand binding. DISCUSSION: CNNs could improve tau PET's role in early disease and extend the utility of tau PET across generations of radioligands.

Identifiers

PMID35005197
PMCPMC8719427
OpenAlexW4206124362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.